← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

EG logoEverest Re Group, Ltd.(EG)Earnings, Financials & Key Ratios

EG•NYSE•Insurance & Managed Care
$351.90
$14.18B mkt cap·9.3× P/E·Price updated May 6, 2026
SectorFinancial ServicesIndustryReinsuranceSub-IndustryProperty and casualty reinsurers
AboutEverest Group, Ltd., through its subsidiaries, provides reinsurance and insurance products in the United States, Bermuda, and internationally. The company operates through Reinsurance Operations and Insurance Operations segments. The Reinsurance Operations segment writes property and casualty reinsurance; and specialty lines of business through reinsurance brokers, as well as directly with ceding companies in the United States, Bermuda, Ireland, Canada, Singapore, Switzerland, and the United Kingdom. The Insurance Operations segment writes property and casualty insurance directly, as well as through brokers, surplus lines brokers, and general agents in the United States, Bermuda, Canada, Europe, South America, France, Germany, Spain, Canada, Chile, the United Kingdom, Ireland, and the Netherlands. The company also provides treaty and facultative reinsurance products; admitted and non-admitted insurance products; and property and casualty reinsurance and insurance coverages, including marine, aviation, surety, errors and omissions liability, directors' and officers' liability, medical malpractice, mortgage reinsurance, other specialty lines, accident and health, and workers' compensation products. In addition, it offers commercial property and casualty insurance products through wholesale and retail brokers, surplus lines brokers, and program administrators. The company was formerly known as Everest Re Group, Ltd. and changed its name to Everest Group, Ltd. in July 2023. The company was founded in 1973 and is headquartered in Hamilton, Bermuda.Show more
  • Revenue$17.32B+1.4%
  • Combined Ratio88.72%-2.8%
  • Net Income$1.59B+15.9%
  • Return on Equity10.85%+7.0%
  • Medical Cost Ratio79.48%-7.1%
  • Operating Margin11.28%+28.9%
  • Net Margin9.19%+14.3%
  • ROA2.68%+3.1%
  • Equity / Assets24.73%+0.4%
  • Book Value per Share373.33+14.9%
  • Tangible BV/Share336.00+15.6%
  • Debt/Equity0.23-45.7%
Analysis→Technical→

EG Key Insights

Everest Re Group, Ltd. (EG) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Profitable underwriting: 88.7% combined ratio
  • ✓Strong 5Y profit CAGR of 25.4%
  • ✓Strong Piotroski F-Score: 7/9
  • ✓13 consecutive years of dividend growth
  • ✓Healthy dividend yield of 2.3%
  • ✓Share count reduced 3.0% through buybacks

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

EG Price & Volume

Everest Re Group, Ltd. (EG) stock price & volume — 10-year historical chart

Loading chart...

EG Growth Metrics

Everest Re Group, Ltd. (EG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years11.8%
5 Years12.53%
3 Years13.05%
TTM-0.49%

Profit CAGR

10 Years4.99%
5 Years25.35%
3 Years38.64%
TTM139.29%

EPS CAGR

10 Years5.53%
5 Years24.26%
3 Years35.58%
TTM150.87%

Return on Capital

10 Years7.27%
5 Years12.11%
3 Years12.64%
Last Year10.87%

EG Recent Earnings

Everest Re Group, Ltd. (EG) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
Apr 29, 2026
EPS
$16.08
Est $13.97
+15.1%
Revenue
$4.1B
Est $4.2B
-2.4%
Q1 2026
Feb 4, 2026
EPS
$13.26
Est $13.36
-0.7%
Revenue
$4.4B
Est $4.5B
-1.5%
Q4 2025
Oct 27, 2025
EPS
$7.54
Est $14.63
-48.5%
Revenue
$4.3B
Est $4.4B
-4.4%
Q3 2025
Jul 30, 2025
EPS
$17.36
Est $15.14
+14.7%
Revenue
$4.4B
Est $3.9B
+13.3%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 29, 2026
$16.08vs $13.97+15.1%
$4.1Bvs $4.2B-2.4%
Q1 2026Feb 4, 2026
$13.26vs $13.36-0.7%
$4.4Bvs $4.5B-1.5%
Q4 2025Oct 27, 2025
$7.54vs $14.63-48.5%
$4.3Bvs $4.4B-4.4%
Q3 2025Jul 30, 2025
$17.36vs $15.14+14.7%
$4.4Bvs $3.9B+13.3%
Based on last 12 quarters of dataView full earnings history →

EG Peer Comparison

Everest Re Group, Ltd. (EG) competitors in Property and casualty reinsurers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
RNR logoRNRRenaissanceRe Holdings Ltd.Direct Competitor13.06B302.635.349.45%26.93%16.59%0.12
TRV logoTRVThe Travelers Companies, Inc.Direct Competitor65.22B301.5910.995.17%12.88%19.12%0.28
MKL logoMKLMarkel CorporationDirect Competitor22.34B1785.5810.55-0.96%10.7%9.56%0.23
PRE logoPREPrenetics Global LimitedDirect Competitor242.43M15.90-3.83201.72%-67.43%-28.88%0.01
ACGL logoACGLArch Capital Group Ltd.Direct Competitor33.74B94.708.1514.27%22.07%19.02%0.11
AXS logoAXSAXIS Capital Holdings LimitedDirect Competitor7.33B99.378.059.05%16.18%16.93%0.23
CB logoCBChubb LimitedProduct Competitor125.61B321.9012.516.47%17.25%13.62%0.28
HIG logoHIGThe Hartford Financial Services Group, Inc.Product Competitor36.71B133.4910.027.1%14.13%22.01%0.23

Compare EG vs Peers

Everest Re Group, Ltd. (EG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs RNR

Most directly comparable listed peer for EG.

Scale Benchmark

vs CB

Larger-name benchmark to compare EG against a more recognizable public peer.

Peer Set

Compare Top 5

vs RNR, TRV, MKL, PRE

EG Income Statement

Everest Re Group, Ltd. (EG) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Revenue6.62B7.36B8.23B9.6B11.33B11.98B14.46B17.08B17.32B17.15B
Revenue Growth %14.29%11.16%11.81%16.61%18.02%5.8%20.68%18.06%1.42%-0.49%
Medical Costs & Claims5.83B7.17B6.63B8.42B9.6B10.63B11.38B14.61B13.76B12.26B
Medical Cost Ratio %87.98%97.4%80.51%87.77%84.75%88.68%78.67%85.53%79.48%71.52%
Gross Profit
795.75M▲ 0%
191.06M▼ 76.0%
1.6B▲ 739.8%
1.17B▼ 26.8%
1.73B▲ 47.2%
1.36B▼ 21.5%
3.08B▲ 127.3%
2.47B▼ 19.9%
3.55B▲ 43.8%
4.88B▲ 0%
Gross Margin %12.02%2.6%19.49%12.23%15.25%11.32%21.33%14.47%20.52%28.48%
Gross Profit Growth %-45.72%-75.99%739.8%-26.83%47.19%-21.47%127.34%-19.9%43.82%-
Operating Expenses376.34M433.24M505.56M588M184M769M931M976M1.6B2.44B
OpEx / Revenue %5.68%5.89%6.14%6.13%1.62%6.42%6.44%5.72%9.24%14.24%
Depreciation & Amortization0000000000
Combined Ratio %93.67%103.29%86.65%93.89%86.37%95.09%85.11%91.25%88.72%85.77%
Operating Income
419.41M▲ 0%
-242.18M▼ 157.7%
1.1B▲ 553.8%
586M▼ 46.7%
1.54B▲ 163.5%
588M▼ 61.9%
2.15B▲ 266.3%
1.5B▼ 30.6%
1.95B▲ 30.7%
2.44B▲ 0%
Operating Margin %6.33%-3.29%13.35%6.11%13.63%4.91%14.89%8.75%11.28%14.23%
Operating Income Growth %-61.87%-157.74%553.79%-46.68%163.48%-61.92%266.33%-30.59%30.7%-
EBITDA451.01M-211.15M1.13B621M1.62B689M2.29B1.64B2.07B2.52B
EBITDA Margin %6.81%-2.87%13.74%6.47%14.27%5.75%15.82%9.62%11.94%14.68%
Interest Expense31.6M31.03M31.69M36M70M101M134M149M139M137M
Non-Operating Income-31.6M-31.03M-31.69M-35M-72M-101M-134M-147M-114M-77M
Pretax Income
419.41M▲ 0%
-242.18M▼ 157.7%
1.1B▲ 553.8%
585M▼ 46.8%
1.55B▲ 164.3%
588M▼ 62.0%
2.15B▲ 266.3%
1.49B▼ 30.7%
1.93B▲ 29.2%
2.42B▲ 0%
Pretax Margin %6.33%-3.29%13.35%6.1%13.65%4.91%14.89%8.74%11.14%14.09%
Income Tax-63.34M-331.22M89.53M71M167M-9M-363M120M339M383M
Effective Tax Rate %-15.1%136.77%8.15%12.14%10.8%-1.53%-16.85%8.04%17.57%15.85%
Net Income
482.75M▲ 0%
89.04M▼ 81.6%
1.01B▲ 1033.7%
514M▼ 49.1%
1.38B▲ 168.3%
597M▼ 56.7%
2.52B▲ 321.6%
1.37B▼ 45.5%
1.59B▲ 15.9%
2.03B▲ 0%
Net Margin %7.29%1.21%12.26%5.36%12.17%4.98%17.4%8.04%9.19%11.86%
Net Income Growth %-51.55%-81.56%1033.7%-49.08%168.29%-56.71%321.61%-45.45%15.88%139.29%
EPS (Diluted)
11.36▲ 0%
2.53▼ 77.7%
24.70▲ 876.3%
12.78▼ 48.3%
34.62▲ 170.9%
15.19▼ 56.1%
60.24▲ 296.6%
31.78▼ 47.2%
37.86▲ 19.1%
50.49▲ 0%
EPS Growth %-52.03%-77.73%876.28%-48.26%170.89%-56.12%296.58%-47.24%19.13%150.87%
EPS (Basic)11.432.5424.7712.8134.6615.1960.1931.7837.86-
Diluted Shares Outstanding41.28M40.93M40.42M39.73M39.3M39M41.3M42.7M41.41M40.28M

EG Balance Sheet

Everest Re Group, Ltd. (EG) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Assets23.59B24.79B27.32B32.71B38.19B39.97B49.4B56.34B62.51B62.34B
Asset Growth %10.65%5.1%10.2%19.72%16.73%4.66%23.6%14.05%10.96%44.75%
Total Investment Assets17.99B17.78B19.94B24.66B28.23B28.47B35.7B39.98B44.11B4M
Long-Term Investments16.36B16.19B18.18B22.65B4.75B18.04B20.56B21.09B25.91B120.31B
Short-Term Investments4.54B4.25B5.82B8.34B23.49B10.43B15.14B18.89B18.2B2.22B
Total Current Assets000030.94B18.98B25.52B31.4B32.35B9.22B
Cash & Equivalents635.07M656.1M808.04M801.65M1.44B1.4B1.44B1.55B1.32B1.42B
Receivables3.49B4.57B4.33B4.69B5.5B6.54B8.22B10.09B12.19B40.28B
Other Current Assets-8.95B-9.81B-11.41B-14.24B000000
Goodwill & Intangibles0000872M962M1.25B1.46B1.55B4.66B
Goodwill0000000000
Intangible Assets0000872M962M1.25B1.46B1.55B0
PP&E (Net)0000000000
Other Assets-16.36B-16.19B-18.18B-22.65B1.63B1.99B2.08B2.39B2.7B-43.6B
Total Liabilities15.22B16.89B18.19B22.99B28.05B31.52B36.2B42.47B47.05B47.05B
Total Debt1.03B1.03B1.03B3.29B5.43B5.43B5.74B5.94B3.59B3.59B
Net Debt395.16M374.47M222.87M2.49B3.99B4.03B4.3B4.39B2.27B2.17B
Long-Term Debt633.39M633.61M633.83M1.91B3.09B3.08B3.39B3.59B3.59B3.59B
Short-Term Debt396.83M396.95M397.07M1.38B2.35B2.35B2.35B2.35B00
Total Current Liabilities000026.47B30.16B34.41B40.4B42.52B933M
Accounts Payable218.02M218.44M291.66M294.35M450M567M650M701M642M0
Deferred Revenue00004.61B5.15B6.62B7.32B7.28B0
Other Current Liabilities-656.32M-669.6M-722.26M-1.89B19.03B22.08B24.63B29.92B34.58B933M
Deferred Taxes1000K1000K00000000
Other Liabilities-633.39M-633.61M-633.83M-1.91B-1.51B-1.72B-1.6B-1.52B948M46.12B
Total Equity
8.37B▲ 0%
7.86B▼ 6.1%
9.13B▲ 16.2%
9.73B▲ 6.5%
10.14B▲ 4.3%
8.44B▼ 16.8%
13.2B▲ 56.4%
13.88B▲ 5.1%
15.46B▲ 11.4%
15.29B▲ 0%
Equity Growth %3.64%-6.08%16.18%6.5%4.25%-16.76%56.4%5.11%11.42%25.72%
Shareholders Equity8.37B7.86B9.13B9.73B10.14B8.44B13.2B13.88B15.46B15.29B
Minority Interest0000000000
Retained Earnings9.68B9.57B10.31B10.57B11.7B12.04B14.27B15.31B16.57B17.14B
Common Stock691K692K694K696K1M1M1M1M1M1M
Accumulated OCI-160.89M-462.56M28.15M534.9M12M-2B-934M-1.14B-52M-462M
Return on Equity (ROE)5.87%1.1%11.88%5.45%13.88%6.43%23.26%10.14%10.85%13.31%
Return on Assets (ROA)2.15%0.37%3.87%1.71%3.89%1.53%5.63%2.6%2.68%3.29%
Equity / Assets35.48%31.7%33.42%29.73%26.55%21.12%26.73%24.63%24.73%24.53%
Debt / Equity0.12x0.13x0.11x0.34x0.54x0.64x0.43x0.43x0.23x0.23x
Book Value per Share202.73192.06225.95244.78257.99216.44319.66324.96373.33379.58
Tangible BV per Share202.73192.06225.95244.78235.80191.77289.47290.75336.00379.58

EG Cash Flow Statement

Everest Re Group, Ltd. (EG) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations1.16B610.07M1.85B2.87B3.83B3.69B4.55B4.96B3.4B3.4B
Operating CF Growth %-15.97%-47.53%203.57%55.18%33.37%-3.6%23.22%8.87%-31.37%-207.72%
Operating CF / Revenue %17.56%8.29%22.5%29.94%33.84%30.83%31.48%29.03%19.64%19.84%
Net Income482.75M89.04M1.01B514M1.38B597M2.52B1.37B1.59B2.03B
Depreciation & Amortization00000000-166M-73M
Stock-Based Compensation30.3M32.37M34.02M39M43M45M49M63M61M55M
Deferred Taxes0-14.51M00000000
Other Non-Cash Items-56.5M241.03M-72.77M-95M30M689M332M-22M309M129M
Working Capital Changes706.15M247.63M881.29M2.42B2.38B2.36B1.66B3.54B1.61B712M
Cash from Investing-732.58M-279.62M-1.41B-3.68B-3.87B-3.42B-5.9B-4.48B-2.43B-1.68B
Capital Expenditures0000000000
Acquisitions0000000000
Purchase of Investments-5.67B-7.22B-7.11B-8.54B-9.97B-8.5B-11.82B-14.16B-10.89B-7.24B
Sale/Maturity of Investments5.21B7.17B5.87B4.91B6.8B6.43B6.39B10.23B8.21B5.09B
Other Investing-280.46M-222.39M-167.04M-52M-702M-1.35B-476M-556M249M469M
Cash from Financing-275.46M-316.59M-275.69M800M674.19M-359M1.41B-383M-1.18B-1.31B
Dividends Paid-207.24M-216.22M-234.32M-249M-247M-255M-288M-334M-335M-330M
Share Repurchases-50M-75.3M-24.6M-200M-225M-61M0-200M-818M-953M
Stock Issued0000001.45B000
Debt Issuance (Net)0001000K1000K01000K1000K00
Other Financing-18.22M-25.07M-16.76M-40M-30.81M-43M-47M-49M-22M-23M
Net Change in Cash
153.15M▲ 0%
21.03M▼ 86.3%
151.94M▲ 622.6%
-6M▼ 103.9%
639.21M▲ 10753.5%
-43M▼ 106.7%
39M▲ 190.7%
112M▲ 187.2%
-231M▼ 306.3%
-152M▲ 0%
Exchange Rate Effect-1.51M7.17M-11.88M3M639K39M-22M16M-28M-19M
Cash at Beginning481.92M635.07M656.1M808.04M801.65M1.44B1.4B1.44B1.55B1.32B
Cash at End635.07M656.1M808.04M801.65M1.44B1.4B1.44B1.55B1.32B1.42B
Free Cash Flow
1.16B▲ 0%
610.07M▼ 47.5%
1.85B▲ 203.6%
2.87B▲ 55.2%
3.83B▲ 33.4%
3.69B▼ 3.6%
4.55B▲ 23.2%
4.96B▲ 8.9%
3.4B▼ 31.4%
2.86B▲ 0%
FCF Growth %-15.97%-47.53%203.57%55.18%33.37%-3.6%23.22%8.87%-31.37%-40.27%
FCF Margin %17.56%8.29%22.5%29.94%33.84%30.83%31.48%29.03%19.64%16.66%
FCF per Share28.1614.9145.8272.3397.5294.74110.24116.0982.1582.15

EG Key Ratios

Everest Re Group, Ltd. (EG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Combined Ratio93.67%103.29%86.65%93.89%86.37%95.09%85.11%91.25%88.72%85.77%
Medical Cost Ratio87.98%97.4%80.51%87.77%84.75%88.68%78.67%85.53%79.48%71.52%
Return on Equity (ROE)5.87%1.1%11.88%5.45%13.88%6.43%23.26%10.14%10.85%13.31%
Return on Assets (ROA)2.15%0.37%3.87%1.71%3.89%1.53%5.63%2.6%2.68%3.29%
Equity / Assets35.48%31.7%33.42%29.73%26.55%21.12%26.73%24.63%24.73%24.53%
Book Value / Share202.73192.06225.95244.78257.99216.44319.66324.96373.33379.58
Debt / Equity0.12x0.13x0.11x0.34x0.54x0.64x0.43x0.43x0.23x0.23x
Revenue Growth14.29%11.16%11.81%16.61%18.02%5.8%20.68%18.06%1.42%-0.49%

EG SEC Filings & Documents

Everest Re Group, Ltd. (EG) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 29, 2026·SEC

Material company update

Apr 13, 2026·SEC

Material company update

Mar 23, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 28, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Oct 31, 2025·SEC

FY 2025

Aug 1, 2025·SEC

FY 2025

May 2, 2025·SEC

EG Frequently Asked Questions

Everest Re Group, Ltd. (EG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Everest Re Group, Ltd. (EG) grew revenue by 1.4% over the past year. Growth has been modest.

Yes, Everest Re Group, Ltd. (EG) is profitable, generating $2.03B in net income for fiscal year 2025 (9.2% net margin).

Dividend & Returns

Yes, Everest Re Group, Ltd. (EG) pays a dividend with a yield of 2.30%. This makes it attractive for income-focused investors.

Everest Re Group, Ltd. (EG) has a return on equity (ROE) of 10.8%. This is reasonable for most industries.

Industry Metrics

Everest Re Group, Ltd. (EG) has a combined ratio of 88.7%. A ratio below 100% indicates underwriting profitability.

Explore More EG

Everest Re Group, Ltd. (EG) financial analysis — history, returns, DCA and operating performance tools

Full EG Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.